A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult | MicrobiomeTrials← Back to trialsNCT07632573
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-05-18Est. Completion: 2026-12-31
Enrollment target: 68 participants Locations- Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Ulcerative Colitis (UC)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027
Inflammatory Bowel Disease (IBD)
Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027